<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39202695</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>01</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2075-1729</ISSN><JournalIssue CitedMedium="Print"><Volume>14</Volume><Issue>8</Issue><PubDate><Year>2024</Year><Month>Jul</Month><Day>29</Day></PubDate></JournalIssue><Title>Life (Basel, Switzerland)</Title><ISOAbbreviation>Life (Basel)</ISOAbbreviation></Journal><ArticleTitle>COVID-19 Coagulopathy.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">953</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/life14080953</ELocationID><Abstract><AbstractText>Coronavirus disease of 2019 (COVID-19) is the respiratory viral infection caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Despite being a primary respiratory illness, it is commonly complicated by systemic involvement of the vasculature leading to arterial and venous thrombosis. In this review, we will focus on the association between COVID-19 and thrombosis. We will highlight the pathophysiology of COVID-19 coagulopathy. The clinical manifestations of COVID-19 vasculopathy will be discussed with a focus on venous and arterial thromboembolic events. COVID-19 vasculopathy and disseminated intravascular coagulation (DIC) are distinguished within, as well as areas of controversy, such as "long COVID". Finally, the current professional guidelines on prevention and treatment of thrombosis associated with SARS-CoV-2 infection will be discussed.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Rettew</LastName><ForeName>Andrew</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Tower Health System, Reading Hospital, West Reading, PA 19611, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garrahy</LastName><ForeName>Ian</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Tower Health System, Reading Hospital, West Reading, PA 19611, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rahimian</LastName><ForeName>Shoja</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Tower Health System, Reading Hospital, West Reading, PA 19611, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brown</LastName><ForeName>Rebecca</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Tower Health System, Reading Hospital, West Reading, PA 19611, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sangha</LastName><ForeName>Navdeep</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Tower Health System, Reading Hospital, West Reading, PA 19611, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>07</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Life (Basel)</MedlineTA><NlmUniqueID>101580444</NlmUniqueID><ISSNLinking>2075-1729</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">coagulopathy</Keyword><Keyword MajorTopicYN="N">vasculopathy</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>7</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>7</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>7</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>8</Month><Day>31</Day><Hour>9</Hour><Minute>49</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>8</Month><Day>31</Day><Hour>9</Hour><Minute>48</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>8</Month><Day>29</Day><Hour>1</Hour><Minute>20</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>7</Month><Day>29</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39202695</ArticleId><ArticleId IdType="pmc">PMC11355811</ArticleId><ArticleId IdType="doi">10.3390/life14080953</ArticleId><ArticleId IdType="pii">life14080953</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Wichmann D., Sperhake J.P., Lutgehetmann M., Steurer S., Edler C., Heinemann A. Autopsy findings and venous thromboembolism in patients with COVID-19. Ann. Intern. Med. 2020;173:268&#x2013;277. doi: 10.7326/M20-2003.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/M20-2003</ArticleId><ArticleId IdType="pmc">PMC7240772</ArticleId><ArticleId IdType="pubmed">32374815</ArticleId></ArticleIdList></Reference><Reference><Citation>Klok F.A., Kruip M.J.H.A., van der Meer N.J.M., Arbous M.S., Gommers D., Kant K.M. Confirmation of the high cumulative incidence of thrombotic complications in critically ill ICU patients with COVID-19: An updated analysis. Thromb. Res. 2020;191:148&#x2013;150. doi: 10.1016/j.thromres.2020.04.041.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.thromres.2020.04.041</ArticleId><ArticleId IdType="pmc">PMC7192101</ArticleId><ArticleId IdType="pubmed">32381264</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu X., Chang X.N., Pan H.X., Su H., Huang B., Yang M. Pathological changes of the spleen in ten patients with coronavirus disease 2019 (COVID-19) by postmortem needle autopsy. Zhonghua Bing Li Xue Za Zhi. 2020;49:576&#x2013;582.</Citation><ArticleIdList><ArticleId IdType="pubmed">32340089</ArticleId></ArticleIdList></Reference><Reference><Citation>Juthani P., Bhojwani R., Gupta N. Coronavirus disease 2019 (COVID-19) manifestation as acute myocardial infarction in a young, healthy male. Case Rep Infect Dis. 2020;2020:8864985. doi: 10.1155/2020/8864985.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2020/8864985</ArticleId><ArticleId IdType="pmc">PMC7364231</ArticleId><ArticleId IdType="pubmed">32724685</ArticleId></ArticleIdList></Reference><Reference><Citation>Oxley T.J., Mocco J., Majidi S., Kellner C.P., Shoirah H., Singh I.P. Large-vessel stroke as a presenting feature of COVID-19 in the young. N. Engl. J. Med. 2020;382:e60. doi: 10.1056/NEJMc2009787.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc2009787</ArticleId><ArticleId IdType="pmc">PMC7207073</ArticleId><ArticleId IdType="pubmed">32343504</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanff T.C., Mohareb A.M., Giri J., Cohen J.B., Chirinos J.A. Thrombosis in COVID-19. Am. J. Hematol. 2020;95:1578&#x2013;1589. doi: 10.1002/ajh.25982.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ajh.25982</ArticleId><ArticleId IdType="pmc">PMC7674272</ArticleId><ArticleId IdType="pubmed">32857878</ArticleId></ArticleIdList></Reference><Reference><Citation>Lodigiani C., Iapichino G., Carenzo L., Cecconi M., Ferrazzi P., Sebastian T., Kucher N., Studt J.-D., Sacco C., Bertuzzi A., et al. Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan. Thromb. Res. 2020;191:9&#x2013;14. doi: 10.1016/j.thromres.2020.04.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.thromres.2020.04.024</ArticleId><ArticleId IdType="pmc">PMC7177070</ArticleId><ArticleId IdType="pubmed">32353746</ArticleId></ArticleIdList></Reference><Reference><Citation>Llitjos J.F., Leclerc M., Chochois C., Monsallier J.M., Ramakers M., Auvray M., Merouani K. High incidence of venous thromboembolic events in anticoagulated severe COVID-19 patients. J. Thromb. Haemost. 2020;18:1743&#x2013;1746. doi: 10.1111/jth.14869.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.14869</ArticleId><ArticleId IdType="pmc">PMC7264774</ArticleId><ArticleId IdType="pubmed">32320517</ArticleId></ArticleIdList></Reference><Reference><Citation>Cui S., Chen S., Li X., Liu S., Wang F. Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia. J. Thromb. Haemost. 2020;18:1421&#x2013;1424. doi: 10.1111/jth.14830.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.14830</ArticleId><ArticleId IdType="pmc">PMC7262324</ArticleId><ArticleId IdType="pubmed">32271988</ArticleId></ArticleIdList></Reference><Reference><Citation>Ren B., Yan F., Deng Z., Zhang S., Xiao L., Wu M., Cai L. Extremely high incidence of lower extremity deep venous thrombosis in 48 patients with severe COVID-19 in Wuhan. Circulation. 2020;142:181&#x2013;183. doi: 10.1161/CIRCULATIONAHA.120.047407.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.120.047407</ArticleId><ArticleId IdType="pubmed">32412320</ArticleId></ArticleIdList></Reference><Reference><Citation>Poissy J., Goutay J., Caplan M., Parmentier E., Duburcq T., Lassalle F., Lille ICU Haemostasis COVID-19 Group Pulmonary embolism in patients with COVID-19: Awareness of an increased prevalence. Circulation. 2020;142:184&#x2013;186. doi: 10.1161/CIRCULATIONAHA.120.047430.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.120.047430</ArticleId><ArticleId IdType="pubmed">32330083</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh B., Aly R., Kaur P., Gupta S., Vasudev R., Virk H.S. COVID-19 infection and arterial thrombosis: Report of three cases. Ann. Vasc. Surg. 2020;70:314&#x2013;317. doi: 10.1016/j.avsg.2020.08.115.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.avsg.2020.08.115</ArticleId><ArticleId IdType="pmc">PMC7462876</ArticleId><ArticleId IdType="pubmed">32889160</ArticleId></ArticleIdList></Reference><Reference><Citation>Choudry F.A., Hamshere S.M., Rathod K.S., Akhtar M.M., Archbold R.A., Guttmann O.P. High thrombus burden in patients with COVID-19 presenting with ST-segment elevation myocardial infarction. J. Am. Coll. Cardiol. 2020;76:1168&#x2013;1176. doi: 10.1016/j.jacc.2020.07.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2020.07.022</ArticleId><ArticleId IdType="pmc">PMC7833185</ArticleId><ArticleId IdType="pubmed">32679155</ArticleId></ArticleIdList></Reference><Reference><Citation>Gheblawi M., Wang K., Viveiros A., Nguyen Q., Zhong J.C., Turner A.J., Raizada M.K., Grant M.B., Oudit G.Y. Angiotensin-converting enzyme 2: SARS-CoV-2 receptor and regulator of the renin-angiotensin system: Celebrating the 20th anniversary of the discovery of ACE2. Circ. Res. 2020;126:1456&#x2013;1474. doi: 10.1161/CIRCRESAHA.120.317015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.120.317015</ArticleId><ArticleId IdType="pmc">PMC7188049</ArticleId><ArticleId IdType="pubmed">32264791</ArticleId></ArticleIdList></Reference><Reference><Citation>Santos R.A., Sampaio W.O., Alzamora A.C., Motta-Santos D., Alenina N., Bader M., Campagnole-Santos M.J. The ACE2/Angiotensin-(1-7)/MAS Axis of the Renin-Angiotensin System: Focus on Angiotensin-(1-7) Physiol. Rev. 2018;98:505&#x2013;553. doi: 10.1152/physrev.00023.2016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/physrev.00023.2016</ArticleId><ArticleId IdType="pmc">PMC7203574</ArticleId><ArticleId IdType="pubmed">29351514</ArticleId></ArticleIdList></Reference><Reference><Citation>Fried J.A., Ramasubbu K., Bhatt R., Topkara V.K., Clerkin K.J., Horn E. The variety of cardiovascular presentations of COVID-19. Circulation. 2020;141:1930&#x2013;1936. doi: 10.1161/CIRCULATIONAHA.120.047164.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.120.047164</ArticleId><ArticleId IdType="pmc">PMC7314498</ArticleId><ArticleId IdType="pubmed">32243205</ArticleId></ArticleIdList></Reference><Reference><Citation>Tadros A., Hughes D.P., Dunmore B.J., Brindle N.P. ABIN-2 protects endothelial cells from death and has a role in the antiapoptotic effect of angiopoietin-1. Blood. 2003;102:4407&#x2013;4409. doi: 10.1182/blood-2003-05-1602.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2003-05-1602</ArticleId><ArticleId IdType="pubmed">12933576</ArticleId></ArticleIdList></Reference><Reference><Citation>Iba T., Levy J.H., Connors J.M., Warkentin T.E., Thachil J., Levi M. The unique characteristics of COVID-19 coagulopathy. Crit. Care. 2020;24:360. doi: 10.1186/s13054-020-03077-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-020-03077-0</ArticleId><ArticleId IdType="pmc">PMC7301352</ArticleId><ArticleId IdType="pubmed">32552865</ArticleId></ArticleIdList></Reference><Reference><Citation>Merad M., Martin J.C. Pathological inflammation in patients with COVID-19: A key role for monocytes and macrophages. Nat. Rev. Immunol. 2020;20:355&#x2013;362. doi: 10.1038/s41577-020-0331-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-020-0331-4</ArticleId><ArticleId IdType="pmc">PMC7201395</ArticleId><ArticleId IdType="pubmed">32376901</ArticleId></ArticleIdList></Reference><Reference><Citation>Favaloro E.J., Henry B.M., Lippi G. Increased vWF and decreased ADAMTS-13 in COVID-19: Creating a milieu for (micro)thrombosis. Semin. Thromb. Hemost. 2021;47:400&#x2013;418. doi: 10.1055/s-0041-1727282.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0041-1727282</ArticleId><ArticleId IdType="pubmed">33893632</ArticleId></ArticleIdList></Reference><Reference><Citation>Englisch C.N., Tschernig T., Flockerzi F., Meier C., Bohle R.M. Lesions in the lungs of fatal corona virus disease COVID-19. Ann. Anat. 2021;234:151657. doi: 10.1016/j.aanat.2020.151657.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.aanat.2020.151657</ArticleId><ArticleId IdType="pmc">PMC7713602</ArticleId><ArticleId IdType="pubmed">33279630</ArticleId></ArticleIdList></Reference><Reference><Citation>MacKman N., Antoniak S., Wolberg A.S., Kasthuri R., Key N.S. Coagulation abnormalities and thrombosis in patients infected with SARS-CoV-2 and other pandemic viruses. Arterioscler. Thromb. Vasc. Biol. 2020;40:2033&#x2013;2044. doi: 10.1161/ATVBAHA.120.314514.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/ATVBAHA.120.314514</ArticleId><ArticleId IdType="pmc">PMC7447001</ArticleId><ArticleId IdType="pubmed">32657623</ArticleId></ArticleIdList></Reference><Reference><Citation>Nougier C., Benoit R., Simon M., Desmurs-Clavel H., Marcotte G., Argaud L., David J.S., Bonnet A., Negrier C., Dargaud Y. Hypofibrinolytic state and high thrombin generation may play a major role in SARS-CoV2 associated thrombosis. J. Thromb. Haemost. 2020;18:2215&#x2013;2219. doi: 10.1111/jth.15016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.15016</ArticleId><ArticleId IdType="pmc">PMC7405476</ArticleId><ArticleId IdType="pubmed">32668058</ArticleId></ArticleIdList></Reference><Reference><Citation>Subramaniam S., Jurk K., Hobohm L., J&#xe4;ckel S., Saffarzadeh M., Schwierczek K., Wenzel P., Langer F., Reinhardt C., Ruf W. Distinct contributions of complement factors to platelet activation and fibrin formation in venous thrombus development. Blood. 2017;129:2291&#x2013;2302. doi: 10.1182/blood-2016-11-749879.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2016-11-749879</ArticleId><ArticleId IdType="pmc">PMC5399485</ArticleId><ArticleId IdType="pubmed">28223279</ArticleId></ArticleIdList></Reference><Reference><Citation>Wojta J., Huber K., Valent P. New aspects in thrombotic research: Complement induced switch in mast cells from a profibrinolytic to a prothrombotic phenotype. Pathophysiol. Haemost. Thromb. 2003;33:438&#x2013;441. doi: 10.1159/000083842.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000083842</ArticleId><ArticleId IdType="pubmed">15692257</ArticleId></ArticleIdList></Reference><Reference><Citation>Zinellu A., Mangoni A.A. Serum Complement C3 and C4 and COVID-19 Severity and Mortality: A Systematic Review and Meta-Analysis with Meta-Regression. Front. Immunol. 2021;12:696085. doi: 10.3389/fimmu.2021.696085.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.696085</ArticleId><ArticleId IdType="pmc">PMC8215447</ArticleId><ArticleId IdType="pubmed">34163491</ArticleId></ArticleIdList></Reference><Reference><Citation>Mastellos D.C., Pires da Silva B.G.P., Fonseca B.A.L., Fonseca N.P., Auxiliadora-Martins M., Mastaglio S., Ruggeri A., Sironi M., Radermacher P., Chrysanthopoulou A., et al. Complement C3 vs C5 inhibition in severe COVID-19: Early clinical findings reveal differential biological efficacy. Clin. Immunol. 2020;220:108598. doi: 10.1016/j.clim.2020.108598.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clim.2020.108598</ArticleId><ArticleId IdType="pmc">PMC7501834</ArticleId><ArticleId IdType="pubmed">32961333</ArticleId></ArticleIdList></Reference><Reference><Citation>Skendros P., Mitsios A., Chrysanthopoulou A., Mastellos D.C., Metallidis S., Rafailidis P., Ntinopoulou M., Sertaridou E., Tsironidou V., Tsigalou C., et al. Complement and tissue factor-enriched neutrophil extracellular traps are key drivers in COVID-19 immunothrombosis. J. Clin. Investig. 2020;130:6151&#x2013;6157. doi: 10.1172/JCI141374.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI141374</ArticleId><ArticleId IdType="pmc">PMC7598040</ArticleId><ArticleId IdType="pubmed">32759504</ArticleId></ArticleIdList></Reference><Reference><Citation>Laridan E., Martinod K., De Meyer S.F. Neutrophil extracellular traps in arterial and venous thrombosis. Semin. Thromb. Hemost. 2019;45:86&#x2013;93. doi: 10.1055/s-0038-1677040.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0038-1677040</ArticleId><ArticleId IdType="pubmed">30634198</ArticleId></ArticleIdList></Reference><Reference><Citation>Idell S. Coagulation, fibrinolysis, and fibrin deposition in acute lung injury. Crit. Care Med. 2003;31((Suppl. S4)):S213&#x2013;S220. doi: 10.1097/01.CCM.0000057846.21303.AB.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.CCM.0000057846.21303.AB</ArticleId><ArticleId IdType="pubmed">12682443</ArticleId></ArticleIdList></Reference><Reference><Citation>Wright F.L., Vogler T.O., Moore E.E., Moore H.B., Wohlauer M.V., Urban S., Nydam T.L., Moore P.K., McIntyre R.C., Jr. Fibrinolysis shutdown correlation with thromboembolic events in severe COVID-19 infection. J. Am. Coll. Surg. 2020;231:193&#x2013;203. doi: 10.1016/j.jamcollsurg.2020.05.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jamcollsurg.2020.05.007</ArticleId><ArticleId IdType="pmc">PMC7227511</ArticleId><ArticleId IdType="pubmed">32422349</ArticleId></ArticleIdList></Reference><Reference><Citation>Khismatullin R.R., Ponomareva A.A., Nagaswami C., Ivaeva R.A., Montone K.T., Weisel J.W., Litvinov R.I. Pathology of lung-specific thrombosis and inflammation in COVID-19. J. Thromb. Haemost. 2021;19:3062&#x2013;3072. doi: 10.1111/jth.15532.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.15532</ArticleId><ArticleId IdType="pmc">PMC8646730</ArticleId><ArticleId IdType="pubmed">34538029</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu S., Liu Y., Ding Y., Luo S., Zheng X., Wu X., Liu Z., Ilyas I., Chen S., Han S., et al. The zinc finger transcription factor, KLF2, protects against COVID-19 associated endothelial dysfunction. Signal Transduct. Target. Ther. 2021;6:266. doi: 10.1038/s41392-021-00690-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-021-00690-5</ArticleId><ArticleId IdType="pmc">PMC8273371</ArticleId><ArticleId IdType="pubmed">34253708</ArticleId></ArticleIdList></Reference><Reference><Citation>G&#xf3;mez-Mesa J.E., Galindo-Coral S., Montes M.C., Mu&#xf1;oz Martin A.J. Thrombosis and Coagulopathy in COVID-19. Curr. Probl. Cardiol. 2021;46:100742. doi: 10.1016/j.cpcardiol.2020.100742.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cpcardiol.2020.100742</ArticleId><ArticleId IdType="pmc">PMC7605852</ArticleId><ArticleId IdType="pubmed">33243440</ArticleId></ArticleIdList></Reference><Reference><Citation>Levi M., Scully M. How I treat disseminated intravascular coagulation. Blood. 2018;131:845&#x2013;854. doi: 10.1182/blood-2017-10-804096.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2017-10-804096</ArticleId><ArticleId IdType="pubmed">29255070</ArticleId></ArticleIdList></Reference><Reference><Citation>Iba T., Warkentin T.E., Thachil J., Levi M., Levy J.H. Proposal of the Definition for COVID-19-Associated Coagulopathy. J. Clin. Med. 2021;10:191. doi: 10.3390/jcm10020191.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm10020191</ArticleId><ArticleId IdType="pmc">PMC7827226</ArticleId><ArticleId IdType="pubmed">33430431</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Samkari H., Karp Leaf R.S., Dzik W.H., Carlson J.C.T., Fogerty A.E., Waheed A., Goodarzi K., Bendapudi P.K., Bornikova L., Gupta S., et al. COVID-19 and coagulation: Bleeding and thrombotic manifestations of SARS-CoV-2 infection. Blood. 2020;136:489&#x2013;500. doi: 10.1182/blood.2020006520.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood.2020006520</ArticleId><ArticleId IdType="pmc">PMC7378457</ArticleId><ArticleId IdType="pubmed">32492712</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah S., Shah K., Patel S.B., Patel F.S., Osman M., Velagapudi P., Turagam M.K., Lakkireddy D., Garg J. Elevated D-Dimer Levels Are Associated With Increased Risk of Mortality in Coronavirus Disease 2019: A Systematic Review and Meta-Analysis. Cardiol. Rev. 2020;28:295&#x2013;302. doi: 10.1097/CRD.0000000000000330.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CRD.0000000000000330</ArticleId><ArticleId IdType="pmc">PMC7437424</ArticleId><ArticleId IdType="pubmed">33017364</ArticleId></ArticleIdList></Reference><Reference><Citation>Levi M., Thachil J., Iba T., Levy J.H. Coagulation abnormalities and thrombosis in patients with COVID-19. Lancet Haematol. 2020;7:e438&#x2013;e440. doi: 10.1016/S2352-3026(20)30145-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2352-3026(20)30145-9</ArticleId><ArticleId IdType="pmc">PMC7213964</ArticleId><ArticleId IdType="pubmed">32407672</ArticleId></ArticleIdList></Reference><Reference><Citation>Gerber G.F., Chaturvedi S. How to recognize and manage COVID-19-associated coagulopathy. Hematol. Am. Soc. Hematol. Educ. Program. 2021;2021:614&#x2013;620. doi: 10.1182/hematology.2021000297.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/hematology.2021000297</ArticleId><ArticleId IdType="pmc">PMC8791093</ArticleId><ArticleId IdType="pubmed">34889412</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang N., Li D., Wang X., Sun Z. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J. Thromb. Haemost. 2020;18:844&#x2013;847. doi: 10.1111/jth.14768.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.14768</ArticleId><ArticleId IdType="pmc">PMC7166509</ArticleId><ArticleId IdType="pubmed">32073213</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Ani F., Chehade S., Lazo-Langner A. Thrombosis risk associated with COVID-19 infection. A scoping review. Thromb. Res. 2020;192:152&#x2013;160. doi: 10.1016/j.thromres.2020.05.039.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.thromres.2020.05.039</ArticleId><ArticleId IdType="pmc">PMC7255332</ArticleId><ArticleId IdType="pubmed">32485418</ArticleId></ArticleIdList></Reference><Reference><Citation>Thachil J., Tang N., Gando S., Falanga A., Cattaneo M., Levi M., Clark C., Iba T. ISTH interim guidance on recognition and management of coagulopathy in COVID-19. J. Thromb. Haemost. 2020;18:1023&#x2013;1026. doi: 10.1111/jth.14810.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.14810</ArticleId><ArticleId IdType="pmc">PMC9906133</ArticleId><ArticleId IdType="pubmed">32338827</ArticleId></ArticleIdList></Reference><Reference><Citation>Angelini D.E., Kaatz S., Rosovsky R.P., Zon R.L., Pillai S., Robertson W.E., Elavalakanar P., Patell R., Khorana A. COVID-19 and venous thromboembolism: A narrative review. Res. Pract. Thromb. Haemost. 2022;6:e12666. doi: 10.1002/rth2.12666.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rth2.12666</ArticleId><ArticleId IdType="pmc">PMC8847419</ArticleId><ArticleId IdType="pubmed">35224417</ArticleId></ArticleIdList></Reference><Reference><Citation>Fahmy O.H., Daas F.M., Salunkhe V., Petrey J.L., Cosar E.F., Ramirez J., Akca O. Is Microthrombosis the Main Pathology in Coronavirus Disease 2019 Severity?-A Systematic Review of the Postmortem Pathologic Findings. Crit. Care Explor. 2021;3:e0427. doi: 10.1097/CCE.0000000000000427.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCE.0000000000000427</ArticleId><ArticleId IdType="pmc">PMC8140776</ArticleId><ArticleId IdType="pubmed">34036278</ArticleId></ArticleIdList></Reference><Reference><Citation>Sakr Y., Giovini M., Leone M., Pizzilli G., Kortgen A., Bauer M., Tonetti T., Duclos G., Zieleskiewicz L., Buschbeck S., et al. Pulmonary embolism in patients with coronavirus disease-2019 (COVID-19) pneumonia: A narrative review. Ann. Intensive Care. 2020;10:124. doi: 10.1186/s13613-020-00741-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13613-020-00741-0</ArticleId><ArticleId IdType="pmc">PMC7492788</ArticleId><ArticleId IdType="pubmed">32953201</ArticleId></ArticleIdList></Reference><Reference><Citation>Suh Y.J., Hong H., Ohana M., Bompard F., Revel M.-P., Valle C., Gervaise A., Poissy J., Susen S., H&#xe9;kimian G., et al. Pulmonary embolism and deep vein thrombosis in COVID-19: A systematic review and meta-analysis. Radiology. 2021;298:E70&#x2013;E80. doi: 10.1148/radiol.2020203557.</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiol.2020203557</ArticleId><ArticleId IdType="pmc">PMC7745997</ArticleId><ArticleId IdType="pubmed">33320063</ArticleId></ArticleIdList></Reference><Reference><Citation>Malas M.B., Naazie I.N., Elsayed N., Mathlouthi A., Marmor R., Clary B. Thromboembolism risk of COVID-19 is high and associated with a higher risk of mortality: A systematic review and meta-analysis. EClinicalMedicine. 2020;29:100639. doi: 10.1016/j.eclinm.2020.100639.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2020.100639</ArticleId><ArticleId IdType="pmc">PMC7679115</ArticleId><ArticleId IdType="pubmed">33251499</ArticleId></ArticleIdList></Reference><Reference><Citation>Gabet A., Grave C., Tuppin P., Olie V., Emmerich J. One Year Prevalence of Venous Thromboembolism in Hospitalized COVID-19 Patients in France: Patients&#x2019; Characteristics, Time Trends, and Outcomes. Thromb. Haemost. 2022;122:1532&#x2013;1541. doi: 10.1055/s-0042-1743475.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0042-1743475</ArticleId><ArticleId IdType="pubmed">35288889</ArticleId></ArticleIdList></Reference><Reference><Citation>Pasha A.K., McBane R.D., Chaudhary R., Padrnos L.J., Wysokinska E., Pruthi R., Ashrani A., Daniels P., Sridharan M., Wysokinski W.E., et al. Timing of venous thromboembolism diagnosis in hospitalized and non-hospitalized patients with COVID-19. Thromb. Res. 2021;207:150&#x2013;157. doi: 10.1016/j.thromres.2021.09.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.thromres.2021.09.021</ArticleId><ArticleId IdType="pmc">PMC8495042</ArticleId><ArticleId IdType="pubmed">34649175</ArticleId></ArticleIdList></Reference><Reference><Citation>Connors J.M., Levy J.H. COVID-19 and its implications for thrombosis and anticoagulation. Blood. 2020;135:2033&#x2013;2040. doi: 10.1182/blood.2020006000.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood.2020006000</ArticleId><ArticleId IdType="pmc">PMC7273827</ArticleId><ArticleId IdType="pubmed">32339221</ArticleId></ArticleIdList></Reference><Reference><Citation>Kato S., Ishiwata Y., Aoki R., Iwasawa T., Hagiwara E., Ogura T., Utsunomiya D. Imaging of COVID-19: An update of current evidences. Diagn. Interv. Imaging. 2021;102:493&#x2013;500. doi: 10.1016/j.diii.2021.05.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.diii.2021.05.006</ArticleId><ArticleId IdType="pmc">PMC8148573</ArticleId><ArticleId IdType="pubmed">34088635</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu S., Hong V., Sy L.S., Glenn S.C., Ryan D.S., Morrissette K.L., Nelson J.C., Hambidge S.J., Crane B., Zerbo O., et al. Changes in incidence rates of outcomes of interest in vaccine safety studies during the COVID-19 pandemic. Vaccine. 2022;40:3150&#x2013;3158. doi: 10.1016/j.vaccine.2022.04.037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2022.04.037</ArticleId><ArticleId IdType="pmc">PMC9013605</ArticleId><ArticleId IdType="pubmed">35465977</ArticleId></ArticleIdList></Reference><Reference><Citation>Kashi M., Jacquin A., Dakhil B., Zaimi R., Mah&#xe9; E., Tella E., Bagan P. Severe arterial thrombosis associated with COVID-19 infection. Thromb. Res. 2020;192:75&#x2013;77. doi: 10.1016/j.thromres.2020.05.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.thromres.2020.05.025</ArticleId><ArticleId IdType="pmc">PMC7229939</ArticleId><ArticleId IdType="pubmed">32425264</ArticleId></ArticleIdList></Reference><Reference><Citation>Weidemann A., Johnson R. Biology of HIF-1&#x3b1;. Cell Death Differ. 2008;15:621&#x2013;627. doi: 10.1038/cdd.2008.12.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cdd.2008.12</ArticleId><ArticleId IdType="pubmed">18259201</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheung S., Quiwa J.C., Pillai A., Onwu C., Tharayil Z.J., Gupta R. Superior mesenteric artery thrombosis and acute intestinal ischemia as a consequence of COVID-19 infection. Am. J. Case Rep. 2020;21:e925753-1. doi: 10.12659/AJCR.925753.</Citation><ArticleIdList><ArticleId IdType="doi">10.12659/AJCR.925753</ArticleId><ArticleId IdType="pmc">PMC7417027</ArticleId><ArticleId IdType="pubmed">32724028</ArticleId></ArticleIdList></Reference><Reference><Citation>Melazzini F., Reduzzi M., Quaglini S., Fumoso F., Lenti M.V., Di Sabatino A. Diagnostic delay of pulmonary embolism in COVID-19 patients. Front. Med. 2021;8:637375. doi: 10.3389/fmed.2021.637375.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2021.637375</ArticleId><ArticleId IdType="pmc">PMC8119630</ArticleId><ArticleId IdType="pubmed">33996852</ArticleId></ArticleIdList></Reference><Reference><Citation>Michelen M., Manoharan L., Elkheir N., Cheng V., Dagens A., Hastie C., O&#x2019;Hara M., Suett J., Dahmash D., Bugaeva P., et al. Characterising long COVID: A living systematic review. BMJ Glob. Health. 2021;6:e005427. doi: 10.1136/bmjgh-2021-005427.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjgh-2021-005427</ArticleId><ArticleId IdType="pmc">PMC8478580</ArticleId><ArticleId IdType="pubmed">34580069</ArticleId></ArticleIdList></Reference><Reference><Citation>Han X., Fan Y., Alwalid O., Li N., Jia X., Yuan M., Li Y., Cao Y., Gu J., Wu H., et al. Six-Month follow-up chest CT findings after severe COVID-19 pneumonia. Radiology. 2021;299:E177&#x2013;E186. doi: 10.1148/radiol.2021203153.</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiol.2021203153</ArticleId><ArticleId IdType="pmc">PMC7841877</ArticleId><ArticleId IdType="pubmed">33497317</ArticleId></ArticleIdList></Reference><Reference><Citation>Qin W., Chen S., Zhang Y., Dong F., Zhang Z., Hu B., Zhu Z., Li F., Wang X., Wang Y., et al. Diffusion capacity abnormalities for carbon monoxide in patients with COVID-19 at 3-month follow-up. Eur. Respir. J. 2021;58:2003677. doi: 10.1183/13993003.03677-2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.03677-2020</ArticleId><ArticleId IdType="pmc">PMC7877322</ArticleId><ArticleId IdType="pubmed">33574077</ArticleId></ArticleIdList></Reference><Reference><Citation>Chioh F.W., Fong S.W., Young B.E., Wu K.X., Siau A., Krishnan S., Chan Y.H., Carissimo G., Teo L.L., Gao F., et al. Convalescent COVID-19 patients are susceptible to endothelial dysfunction due to persistent immune activation. Elife. 2021;10:e64909. doi: 10.7554/eLife.64909.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.64909</ArticleId><ArticleId IdType="pmc">PMC7987341</ArticleId><ArticleId IdType="pubmed">33752798</ArticleId></ArticleIdList></Reference><Reference><Citation>Doyle A.J., Thomas W., Retter A., Besser M., MacDonald S., Breen K.A., Desborough M.J., Hunt B.J. Updated hospital associated venous thromboembolism outcomes with 90-days follow-up after hospitalisation for severe COVID-19 in two UK critical care units. Thromb. Res. 2020;196:454&#x2013;456. doi: 10.1016/j.thromres.2020.10.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.thromres.2020.10.007</ArticleId><ArticleId IdType="pmc">PMC7543947</ArticleId><ArticleId IdType="pubmed">33065410</ArticleId></ArticleIdList></Reference><Reference><Citation>Goligher E.C., Bradbury C.A., McVerry B.J., Lawler P.R., Berger J.S., Gong M.N., Carrier M., Reynolds H.R., Kumar A., Turgeon A.F., et al. Activ-4a, REMAP-CAP, ATTACC investigators. Therapeutic Anticoagulation with Heparin in Critically Ill Patients with COVID-19. N. Engl. J. Med. 2021;385:777&#x2013;789.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8362592</ArticleId><ArticleId IdType="pubmed">34351722</ArticleId></ArticleIdList></Reference><Reference><Citation>ATTACC, ACTIV-4a, and REMAP-CAP Investigators Therapeutic anticoagulation with heparin in noncritically ill patients with COVID-19. N. Engl. J. Med. 2021;385:790&#x2013;802. doi: 10.1056/NEJMoa2105911.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2105911</ArticleId><ArticleId IdType="pmc">PMC8362594</ArticleId><ArticleId IdType="pubmed">34351721</ArticleId></ArticleIdList></Reference><Reference><Citation>Sadeghipour P., Talasaz A.H., Rashidi F., Sharif-Kashani B., Beigmohammadi M.T., Farrokhpour M., Sezavar S.H., Payandemehr P., Dabbagh A., Moghadam K.G., et al. Effect of Intermediate-Dose vs Standard-Dose Prophylactic Anticoagulation on Thrombotic Events, Extracorporeal Membrane Oxygenation Treatment, or Mortality among Patients with COVID-19 Admitted to the Intensive Care Unit: The INSPIRATION Randomized Clinical Trial. JAMA. 2021;325:1620&#x2013;1630.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7974835</ArticleId><ArticleId IdType="pubmed">33734299</ArticleId></ArticleIdList></Reference><Reference><Citation>Spyropoulos A.C., Goldin M., Giannis D., Diab W., Wang J., Khanijo S., Mignatti A., Gianos E., Cohen M., Sharifova G., et al. Efficacy and Safety of Therapeutic-Dose Heparin vs Standard Prophylactic or Intermediate-Dose Heparins for Thromboprophylaxis in High-risk Hospitalized Patients with COVID-19: The HEP-COVID Randomized Clinical Trial. JAMA Intern Med. 2021;181:1612&#x2013;1620. doi: 10.1001/jamainternmed.2021.6203.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamainternmed.2021.6203</ArticleId><ArticleId IdType="pmc">PMC8498934</ArticleId><ArticleId IdType="pubmed">34617959</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopes R.D., Furtado R.H., Macedo A.V., Bronhara B., Damiani L.P., Barbosa L.M., de Aveiro Morata J., Ramacciotti E., de Aquino Martins P., de Oliveira A.L., et al. Therapeutic versus prophylactic anticoagulation for patients admitted to hospital with COVID-19 and elevated D-dimer concentration (ACTION): An open-label, multicentre, randomised, controlled trial. Lancet. 2021;397:2253&#x2013;2263. doi: 10.1016/S0140-6736(21)01203-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(21)01203-4</ArticleId><ArticleId IdType="pmc">PMC8177770</ArticleId><ArticleId IdType="pubmed">34097856</ArticleId></ArticleIdList></Reference><Reference><Citation>Connors J.M., Brooks M.M., Sciurba F.C., Krishnan J.A., Bledsoe J.R., Kindzelski A., Baucom A.L., Kirwan B.-A., Eng H., Martin D., et al. Effect of Antithrombotic Therapy on Clinical Outcomes in Outpatients with Clinically Stable Symptomatic COVID-19: The ACTIV-4B Randomized Clinical Trial. JAMA. 2021;326:1703&#x2013;1712. doi: 10.1001/jama.2021.17272.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2021.17272</ArticleId><ArticleId IdType="pmc">PMC8506296</ArticleId><ArticleId IdType="pubmed">34633405</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramacciotti E., Agati L.B., Calderaro D., Aguiar V.C., Spyropoulos A.C., de Oliveira C.C., Dos Santos J.L., Volpiani G.G., Sobreira M.L., Joviliano E.E., et al. Rivaroxaban versus no anticoagulation for post-discharge thromboprophylaxis after hospitalisation for COVID-19 (MICHELLE): An open-label, multicentre, randomised, controlled trial. Lancet. 2022;399:50&#x2013;59. doi: 10.1016/S0140-6736(21)02392-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(21)02392-8</ArticleId><ArticleId IdType="pmc">PMC8673881</ArticleId><ArticleId IdType="pubmed">34921756</ArticleId></ArticleIdList></Reference><Reference><Citation>Barnes G.D., Burnett A., Allen A., Ansell J., Blumenstein M., Clark N.P., Crowther M., Dager W.E., Deitelzweig S.B., Ellsworth S., et al. Thromboembolic prevention and anticoagulant therapy during the COVID-19 pandemic: Updated clinical guidance from the anticoagulation forum. J. Thromb. Thrombolysis. 2022;54:197&#x2013;210. doi: 10.1007/s11239-022-02643-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11239-022-02643-3</ArticleId><ArticleId IdType="pmc">PMC9111941</ArticleId><ArticleId IdType="pubmed">35579732</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowles L., Platton S., Yartey N., Dave M., Lee K., Hart D.P., MacDonald V., Green L., Sivapalaratnam S., Pasi K.J., et al. Lupus Anticoagulant and Abnormal Coagulation Tests in Patients with COVID-19. N. Engl. J. Med. 2020;383:288&#x2013;290. doi: 10.1056/NEJMc2013656.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc2013656</ArticleId><ArticleId IdType="pmc">PMC7217555</ArticleId><ArticleId IdType="pubmed">32369280</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>